Literature DB >> 11553517

Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells.

W Lieberthal1, R Fuhro, C C Andry, H Rennke, V E Abernathy, J S Koh, R Valeri, J S Levine.   

Abstract

The immunosuppressive effect of rapamycin is mediated by inhibition of interleukin-2-stimulated T cell proliferation. We report for the first time that rapamycin also inhibits growth factor-induced proliferation of cultured mouse proximal tubular (MPT; IC(50) ~1 ng/ml) cells and promotes apoptosis of these cells by impairing the survival effects of the same growth factors. On the basis of these in vitro data, we tested the hypothesis that rapamycin would impair recovery of renal function after ischemic acute renal failure induced in vivo by renal artery occlusion (RAO). Rats given daily injections of rapamycin or vehicle were subjected to RAO or sham surgery. Rapamycin had no effect on the glomerular filtration rate (GFR) of sham-operated animals. In rats subjected to RAO, GFR fell to comparable levels 1 day later in vehicle- and rapamycin-treated rats (0.25 +/- 0.08 and 0.12 +/- 0.05 ml. min(-1). 300 g(-1), respectively) (P = not significant). In vehicle-treated rats subjected to RAO, GFR increased to 0.61 +/- 0.08 ml. min(-1). 300 g(-1) on day 3 (P < 0.02 vs. day 1) and then rose further to 0.99 +/- 0.09 ml. min(-1). 300 g(-1) on day 4 (P < 0.02 vs. day 3). By contrast, GFR did not improve in rapamycin-treated rats subjected to RAO over the same time period. Rapamycin also increased apoptosis of tubular cells while markedly reducing their proliferative response after RAO. Furthermore, rapamycin inhibited activation of 70-kDa S6 protein kinase (p70(S6k)) in cultured MPT cells as well as in the renal tissue of rats subjected to RAO. We conclude that rapamycin severely impairs the recovery of renal function after ischemia-reperfusion injury. This effect appears to be due to the combined effects of increased tubular cell loss (via apoptosis) and profound inhibition of the regenerative response of tubular cells. These effects are likely mediated by inhibition of p70(S6k).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553517     DOI: 10.1152/ajprenal.2001.281.4.F693

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  65 in total

1.  Induction of heat shock protein 70 inhibits ischemic renal injury.

Authors:  Zhiyong Wang; Jonathan M Gall; Ramon G B Bonegio; Andrea Havasi; Clayton R Hunt; Michael Y Sherman; John H Schwartz; Steven C Borkan
Journal:  Kidney Int       Date:  2011-01-26       Impact factor: 10.612

2.  New autophagy reporter mice reveal dynamics of proximal tubular autophagy.

Authors:  Ling Li; Zhao V Wang; Joseph A Hill; Fangming Lin
Journal:  J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 10.121

3.  Therapeutics in renal disease: the road ahead for antiproliferative targets.

Authors:  Peter J Nelson; Stuart J Shankland
Journal:  Nephron Exp Nephrol       Date:  2005-12-07

4.  The TIM-1:TIM-4 pathway enhances renal ischemia-reperfusion injury.

Authors:  Song Rong; Joon-Keun Park; Torsten Kirsch; Hideo Yagita; Hisaya Akiba; Olaf Boenisch; Hermann Haller; Nader Najafian; Antje Habicht
Journal:  J Am Soc Nephrol       Date:  2011-02-25       Impact factor: 10.121

5.  Inactivation of Tsc2 in Abcg2 lineage-derived cells drives the appearance of polycystic lesions and fibrosis in the adult kidney.

Authors:  Leslie S Gewin; Megan E Summers; Julie W Harral; Christa F Gaskill; Stellor Nlandu Khodo; Surekha Neelisetty; Timothy M Sullivan; Katharina Hopp; J Jeffrey Reese; Dwight J Klemm; Valentina Kon; Kevin C Ess; Wei Shi; Susan M Majka
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-28

6.  The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells.

Authors:  C T Bussiere; J R T Lakey; A M J Shapiro; G S Korbutt
Journal:  Diabetologia       Date:  2006-08-09       Impact factor: 10.122

7.  Sirolimus rescue of renal failure in children after combined liver-kidney transplantation.

Authors:  Udo Vester; Birgitta Kranz; Silvio Nadalin; Andreas Paul; Jan Becker; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2005-02-19       Impact factor: 3.714

Review 8.  mTOR inhibitors and renal allograft: Yin and Yang.

Authors:  Gianluigi Zaza; Simona Granata; Paola Tomei; Valentina Masola; Giovanni Gambaro; Antonio Lupo
Journal:  J Nephrol       Date:  2014-05-08       Impact factor: 3.902

9.  Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation.

Authors:  Jens Lutz; Klaus Thürmel; Uwe Heemann
Journal:  J Inflamm (Lond)       Date:  2010-05-28       Impact factor: 4.981

10.  Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.

Authors:  Arnd Heiligenhaus; Beatrix Zurek-Imhoff; Martin Roesel; Maren Hennig; Daniela Rammrath; Carsten Heinz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-17       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.